Cargando…
BIBR1532 inhibits proliferation and enhances apoptosis in multiple myeloma cells by reducing telomerase activity
BACKGROUND: Multiple myeloma (MM) is a rare haematological disorder with few therapeutic options. BIBR1532, a telomerase inhibitor, is widely used in cancer treatment and has promising outcomes. In this study, we investigated the efficacy and mechanism of action of BIBR1532 in MM. METHODS: K562 and...
Autores principales: | Zhang, Yuefeng, Yang, Xinxin, Zhou, Hangqun, Yao, Guoli, Zhou, Li, Qian, Chunyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638922/ https://www.ncbi.nlm.nih.gov/pubmed/37953768 http://dx.doi.org/10.7717/peerj.16404 |
Ejemplares similares
-
Knockdown of hTERT and Treatment with BIBR1532 Inhibit Cell Proliferation and Invasion in Endometrial Cancer Cells
por: Kong, Weimin, et al.
Publicado: (2015) -
Glucose restriction decreases telomerase activity and enhances its inhibitor response on breast cancer cells: possible extra-telomerase role of BIBR 1532
por: Wardi, Layal, et al.
Publicado: (2014) -
Zeolitic Imidazolate Framework-8 (ZIF-8) as a Drug Delivery Vehicle for the Transport and Release of Telomerase Inhibitor BIBR 1532
por: Zhang, Shunyu, et al.
Publicado: (2023) -
A Non-Toxic Concentration of Telomerase Inhibitor BIBR1532 Fails to Reduce TERT Expression in a Feeder-Free Induced Pluripotent Stem Cell Model of Human Motor Neurogenesis
por: Pandya, Virenkumar A., et al.
Publicado: (2021) -
The Small Molecule BIBR1532 Exerts Potential Anti-cancer Activities in Preclinical Models of Feline Oral Squamous Cell Carcinoma Through Inhibition of Telomerase Activity and Down-Regulation of TERT
por: Altamura, Gennaro, et al.
Publicado: (2021)